Akers Biosciences Inc (AKER) Issues Earnings Results
Akers Biosciences Inc (NASDAQ:AKER) released its quarterly earnings data on Wednesday. The medical instruments supplier reported ($0.13) EPS for the quarter, Yahoo Finance reports. Akers Biosciences had a negative return on equity of 59.94% and a negative net margin of 89.49%.
Akers Biosciences (NASDAQ:AKER) opened at $0.64 on Thursday. Akers Biosciences has a 52-week low of $0.61 and a 52-week high of $3.05.
Akers Biosciences Company Profile
Akers Biosciences, Inc, together with its subsidiaries, develops, manufactures, and supplies rapid screening and testing products designed to deliver healthcare information to healthcare providers and consumers in the United States and internationally. The companys marketed products include BreathScan, a disposable breath alcohol detector; BreathScan PRO, a quantitative breath alcohol detection system; METRON, a disposable breath ketone device to monitor ketosis; and BreathScan Lync, a non-invasive, quantitative measurement of biological markers for health and wellness.
Receive News & Ratings for Akers Biosciences Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Akers Biosciences Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.